LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Surgical treatment for colorectal cancer: analysis of the influence of an enhanced recovery programme on long-term oncological outcomes-a study protocol for a prospective, multicentre, observational cohort study.

    Ramirez-Rodriguez, Jose-M / Martinez-Ubieto, Javier / Muñoz-Rodes, Jose-L / Rodriguez-Fraile, Jose-R / Garcia-Erce, Jose-A / Blanco-Gonzalez, Javier / Del Valle-Hernandez, Emilio / Abad-Gurumeta, Alfredo / Centeno-Robles, Eugenia / Martinez-Perez, Carolina / Leon-Arellano, Miguel / Echazarreta-Gallego, Estibaliz / Elia-Guedea, Manuela / Pascual-Bellosta, Ana / Miranda-Tauler, Elena / Manuel-Vazquez, Alba / Balen-Rivera, Enrique / Alvarez-Martinez, David / Perez-Peña, Jose /
    Abad-Motos, Ane / Redondo-Villahoz, Elisabeth / Biosta-Perez, Elena / Guadalajara-Labajo, Hector / Ripollés-Melchor, Javier / Latre-Saso, Cristina / Cordoba-Diaz de Laspra, Elena / Sanchez-Guillen, Luis / Cabellos-Olivares, Mercedes / Longas-Valien, Javier / Ortega-Lucea, Sonia / Ocon-Breton, Julia / Arroyo-Sebastian, Antonio / Garcia-Olmo, Damian

    BMJ open

    2020  Volume 10, Issue 10, Page(s) e040316

    Abstract: Introduction: The evidence currently available from enhanced recovery after surgery (ERAS) programmes concerns their benefits in the immediate postoperative period, but there is still very little evidence as to whether their correct implementation ... ...

    Abstract Introduction: The evidence currently available from enhanced recovery after surgery (ERAS) programmes concerns their benefits in the immediate postoperative period, but there is still very little evidence as to whether their correct implementation benefits patients in the long term. The working hypothesis here is that, due to the lower response to surgical aggression and lower rates of postoperative complications, ERAS protocols can reduce colorectal cancer-related mortality. The main objective of this study is to analyse the impact of an ERAS programme for colorectal cancer on 5-year survival. As secondary objectives, we propose to analyse the weight of each of the predefined items in the oncological results as well as the quality of life.
    Methods and analysis: A multicentre prospective cohort study was conducted in patients older than 18 years of age who are scheduled to undergo surgery for colorectal cancer. The study involved 12 hospitals with an implemented enhanced recovery protocol according to the guidelines published by the Spanish National Health Service. The intervention group includes patients with a minimum implementation level of 70%, and the control group includes those who fail to reach this level. Compliance will be studied using 18 key performance indicators, and the results will be analysed using cancer survival indicators, including overall survival, cancer-specific survival and relapse-free survival. The time to recurrence, perioperative morbidity and mortality, hospital stay and quality of life will also be studied, the latter using the validated EuroQol Five questionnaire. The propensity index method will be used to create comparable treatment and control groups, and a multivariate regression will be used to study each variable. The Kaplan-Meier estimator will be used to estimate survival and the log-rank test to make comparisons. A p value of less than 0.05 (two-tailed) will be considered to be significant.
    Ethics and dissemination: Ethical approval for this study was obtained from the Aragon Ethical Committee (C.P.-C.I. PI20/086) on 4 March 2020. The findings of this study will be submitted to peer-reviewed journals (
    Trial registration number: NCT04305314.
    MeSH term(s) Cohort Studies ; Colorectal Neoplasms/surgery ; Humans ; Length of Stay ; Multicenter Studies as Topic ; Neoplasm Recurrence, Local ; Observational Studies as Topic ; Postoperative Complications/epidemiology ; Prospective Studies ; Quality of Life ; State Medicine
    Language English
    Publishing date 2020-10-27
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2020-040316
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Surgical (close lateral internal sphincterotomy) versus chemical (botulinum toxin) sphincterotomy as treatment of chronic anal fissure.

    Arroyo Sebastián, Antonio / Pérez Vicente, Francisco / Miranda Tauler, Elena / Sánchez Romero, Ana / Serrano Paz, Pilar / Calpena Rico, Rafael

    Medicina clinica

    2005  Volume 124, Issue 15, Page(s) 573–575

    Abstract: Background and objective: The aim of this prospective randomized trial was to compare the effectiveness and morbidity of surgical vs chemical sphincterotomy in the treatment of chronic anal fissure after a 3-year follow-up period.: Patients and method! ...

    Abstract Background and objective: The aim of this prospective randomized trial was to compare the effectiveness and morbidity of surgical vs chemical sphincterotomy in the treatment of chronic anal fissure after a 3-year follow-up period.
    Patients and method: Eighty patients with chronic anal fissure were treated either with close lateral internal sphincterotomy (group 1) or with chemical sphincterotomy with 25 U botulinum toxin injected into the internal sphincter (group 2).
    Results: Overall healing was 90% in the close sphincterotomy group and 45% in the toxin botulinum group (p < 0.001). There was a group of patients with clinical factors (duration of disease over 12 months and presence of a sentinel pile before treatment) associated with a higher recurrence of anal fissure. Final percentage of incontinence was 5% in the close sphincterotomy group and 0% in the botulinum toxin group (p > 0.05). All incontinent patients were aged more than 50 years.
    Conclusions: We recommend surgical sphincterotomy as the first therapeutic approach in patients with clinical factors of recurrence. However, we recommend the use of botulinum toxin in patients older than 50 years or with associated risk factors of incontinence, despite the higher rate of recurrence, since it avoids the greater risk of incontinence seen with surgery.
    MeSH term(s) Adult ; Botulinum Toxins/therapeutic use ; Fecal Incontinence/epidemiology ; Fecal Incontinence/etiology ; Female ; Fissure in Ano/complications ; Fissure in Ano/drug therapy ; Fissure in Ano/surgery ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neuromuscular Agents/therapeutic use ; Prospective Studies ; Sphincterotomy, Endoscopic/methods
    Chemical Substances Neuromuscular Agents ; Botulinum Toxins (EC 3.4.24.69)
    Language English
    Publishing date 2005-04-08
    Publishing country Spain
    Document type Clinical Trial ; Comparative Study ; Journal Article ; Randomized Controlled Trial
    ZDB-ID 411607-0
    ISSN 1578-8989 ; 0025-7753
    ISSN (online) 1578-8989
    ISSN 0025-7753
    DOI 10.1157/13074137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top